Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 29, 2007

View Archived Issues

Recent Wellstat patents describe new treatment options for diabetes

Novel therapeutic agents for HIV infection reported in GSK patents

New treatment options for obesity and other metabolic disorders reported in patent literature

Pooled data show dose-related efficacy of fesoterodine in overactive bladder

Effect of KRP-204 on C-fiber urethral afferent nerves suggests benefit in urgency

Cannabinoids reduce contact hypersensitivity in mice

Effects of epratuzumab on B-cells examined in lupus patients

Arena prepares potential wake-promoting agents derived from natural compound

Candidates for the treatment of CCR4-mediated conditions identified at Astellas

Synthesis and in vivo antitumor activity of EC-0225 described at ACS meeting

FDA issues nonapprovable letter for IDM Pharma's mifamurtide NDA

Daiichi Sankyo reports approval of pediatric indication for Fentanyl injection in Japan

First patient treated in Protalix's phase III trial of prGCD for Gaucher's disease

Sanofi-aventis launches 200 mg single-use vial of Eloxatin

Positive results for ImmuneRegen's preclinical Radilex radiation study

Cobalis reports on study of PreHistin for the treatment of ragweed IgE

New LXR modulator with improved biological profile characterized at recent ACS meeting

New serotonin receptor antagonist for the treatment of incontinence described by Recordati

Novel selective norepinephrine reuptake inhibitor profiled by Wyeth

Rosiglitazone XR investigated in Alzheimer's disease

HemispheRx provides update on Alferon N in WNV and HPV projects

Pfizer and Bristol-Myers Squibb finalize collaboration agreement on DGAT-1 inhibitors

Celsion accelerates plans for ThermoDox phase I study in breast cancer

CuraGen and TopoTarget initiate phase I/II trial of combination therapy for AML

Indevus seeks FDA approval for male hypogonadism therapy

GlaxoSmithKline receives EC approval of Atriance for oncology orphan drug indications

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...